In Vitro Antiparasitic Activity and Chemical Composition of the Essential Oil Obtained from the Fruits of Piper cubeba

Abstract

Protozoans of the trypanosomatid family cause the neglected tropical diseases leishmaniasis and trypanosomiasis, for which few drugs are available. In this context our group has recently reported that the essential oil obtained by steam distillation of the fruits of Piper cubeba is active against Schistosoma mansoni. Therefore, we have investigated the in vitro effects of the essential oil against the trypomastigote and amastigote forms of Trypanosoma cruzi isolated from an LLCMK₂ cell line culture and the promastigote forms of Leishmania amazonensis. The in vitro activity of the essential oil against trypomastigotes of T. cruzi increased upon rising concentrations, giving IC₅₀ values of 45.5 and 87.9 µg · mL⁻¹ against trypomastigotes and amastigotes, respectively. The essential oil was not active against L. amazonensis, since it displayed lyses of only 24 % at 400 µg · mL⁻¹, and an IC₅₀ of 326.5 µg · mL⁻¹. Therefore, the essential oil should be further investigated to determine the compounds responsible for the observed activities, as well as its mechanism of action.

Key words

Piper cubeba - Piperaceae - essential oil - trypanocidal activity - leishmanicidal activity

• References

• 1 Stuart K, Brun R, Croft S, Fairlamb A, Gürtler RE, McKerrow J, Reed S, Tarleton R. Kinetoplastids: related protozoan pathogens, different diseases. J Clin Invest 2008; 118: 1301-1310
• 2 Coura JR. Chagas disease: what is known and what is needed – a background article. Mem Inst Oswaldo Cruz 2007; 102: 113-122
• 3 Schmidt TJ, Khalid SA, Romanha AJ, Alves TMA, Biavatti MW, Brun R, Da Costa FB, de Castro SL, Ferreira VF, de Lacerda MVG, Lago JHG, Leon LL, Lopes NP, das Neves Amorim RC, Niehues M, Ogungbe IV, Pohlit AM, Scotti MT, Setzer WN, Soeiro NC, Steinde M, Tempone AG. The potential of secondary metabolites from plants as drugs or leads against protozoan neglected diseases – part I. Cur Med Chem 2012; 19: 2176-2228
• 4 Rocha MO, Teixeira MM, Ribeiro AL. An update on the management of Chagas cardiomyopathy. Exp Rev Antiinfect Ther 2007; 5: 727-743
• 5 Rassi AJR, Rassi A, Marin-Neto JÁ. Chagas disease. Lancet 2010; 375: 1388-1402
• 6 Parker ER, Sethi A. Chagas disease: coming to a place near you. Dermatol Clin 2011; 29: 53-62
• 7 Raman VS, Duthie MS, Fox CB, Matlashewski G, Reed SG. Adjuvants for Leishmania vaccines: from models to clinical application. Front Immunol 2012; 3: 144
• 8 WHO. Chagas disease (American trypanosomiasis) (2011). Available at http://www.who.int/mediacentre/factsheets/fs340/en/index.html Accessed January 12, 2013
• 9 WHO. Leishmaniasis: the vector (2011). Available at http://www.who.int/leishmaniasis/en/index.html Accessed November 24, 2012
• 10 Rezende KCS, Lucarini R, Símaro GV, Esperandim VR, Ferreira DS, Magalhães LG, Cunha WR, Bastos JK, Silva MLA. Leishmanicidal effect of derivatives of dibenzylbutirolactonic lignans from Piper cubeba . Planta Med 2012; 11: 78
• 11 Hannaert V. Sleeping sickness pathogen (Trypanosoma brucei) and natural products: therapeutic targets and screening systems. Planta Med 2011; 77: 586-597
• 12 Magalhães LG, Souza JM, Wakabayashi KAL, Laurentiz R, Vinhólis AHC, Rezende KCS, Simaro GV, Bastos JK, Rodrigues V, Esperandim VR, Ferreira DS, Crotti AEM, Cunha WR, Silva MLA. In vitro efficacy of the essential oil of Piper cubeba L. (Piperaceae) against Schistosoma mansoni . Parasitol Res 2012; 110: 1747-1754
• 13 Pérez-Rebolledo A. 4-Nitroacetophenone-derived thiosemicarbazones and their copper (II) complexes with significant in vitro anti-trypanosomal activity. Eur J Med Chem 2008; 43: 939-948
• 14 Natera S, Machuca SC, Padroʼn-Nieves M, Romero A, Dıaz E, Ponte-Sucre A. Leishmania spp: proficiency of drug-resistant parasites. Int J Antimicrob Agents 2007; 29: 637-642
• 15 Khare CP. Indian herbal remedies: rational Western therapy, Ayurvedic, and other traditional usage, botany. Berlin: Springer; 2004
• 16 Tóro RM, Gessner AAF, Ceccarelli PS, Furtado NAJC, Albuquerque S, Bastos JK. Activity of the Pinus elliottii resin compounds against Lernaea cyprinacea in vitro . Vet Parasitol 2003; 118: 143-149
• 17 Yadav AK, Tangpu V. Therapeutic efficacy of Zanthoxylum rhetsa DC extract against experimental Hymenolepis diminuta (Cestoda) infections in rats. J Parasitol Dis 2009; 33: 42-47
• 18 Chen W, Vermaak I, Viljoen A. Camphor – a fumigant during the Black Death and a coveted fragrant wood in ancient Egypt and Babylon – a review. Molecules 2013; 18: 5434-5454
• 19 Antony JP, Fyfe L, Smith H. Plant active components – a resource for antiparasitic agents?. Trends Parasitol 2005; 21: 462-468
• 20 Melo NI, Magalhães LG, Carvalho CE, Wakabayashi KAL, Aguiar GP, Ramos RC, Mantovani ALL, Turatti ICC, Rodrigues V, Groppo M, Cunha WR, Veneziani RCS, Crotti AEM. Schistosomicidal activity of the essential oil of Ageratum conyzoides L. (Asteraceae) against Schistosoma mansoni adult worms. Molecules 2011; 16: 762-773
• 21 Ambrósio SR, Arakawa NS, Esperandim VR, de Albuquerque S, Da Costa FB. Trypanocidal activity of pimarane diterpenes from Viguiera arenaria (Asteraceae). Phytother Res 2008; 22: 1413-1415
• 22 Muelas-Serrano S, Nogal-Ruiz JJ, Gómez-Barrio A. Setting of a colorimetric method to determine the viability of Trypanosoma cruzi epimastigotes. Parasitol Res 2000; 86: 999-1002